Outstanding Company Stock. As of the Execution Date, the issued and outstanding capital stock of the Company consists of 20,058,665 Common Shares. All such shares have been duly authorized and validly issued in accordance with the Articles, and have been fully paid and are nonassessable.
Appears in 1 contract
Samples: Edesa Biotech, Inc.
Outstanding Company Stock. As of the Execution Date, the issued and outstanding capital stock of the Company consists of 20,058,665 13,295,403 Common Shares. All such shares have been duly authorized and validly issued in accordance with the Articles, and have been fully paid and are nonassessable.
Appears in 1 contract
Samples: Edesa Biotech, Inc.
Outstanding Company Stock. As of the Execution Date, the issued and outstanding capital stock of the Company consists of 20,058,665 2,181,912 Common Shares. All such shares have been duly authorized and validly issued in accordance with the ArticlesCharter, and have been fully paid and are nonassessable.
Appears in 1 contract
Samples: Equity Distribution Agreement (Enveric Biosciences, Inc.)
Outstanding Company Stock. As of the Execution Date, the issued and outstanding capital stock of the Company consists of 20,058,665 9,608,869 Common Shares and 250 shares of Series A-1 Convertible Preferred Shares. All such shares have been duly authorized and validly issued in accordance with the Articles, and have been fully paid and are nonassessable.
Appears in 1 contract
Samples: Equity Distribution Agreement (Edesa Biotech, Inc.)